mesothelin - OmicsDI

Show results for

Unknown (466)
Genomics (66)
Transcriptomics (62)
Proteomics (12)
Clinical (4)
Methylation profiling (2)
Other (2)
Metabolomics (2)

Organisms

Homo sapiens (40)
Mus musculus (14)
Hypsibius exemplaris (10)
Methanobrevibacter smithii (10)
Azospirillum sp. Sp 7 (10)
Nitrosophilus labii (10)
Paramecium bursaria (10)
Marsilea mutica (10)
Dendrobium huoshanense (10)
Perna canaliculus (10)
Chlorella vulgaris (10)
Bactrocera dorsalis (10)
Equus asinus (10)
Bifidobacterium longum NCC2705 (10)
Limnospira platensis (10)
Sordaria macrospora (10)
Argyrosomus regius (10)
Acinetobacter baumannii ATCC 17978 (10)
Turnip crinkle virus (10)
Pinctada maxima (10)
Sinorhizobium meliloti 2011 (10)
Drosophila mojavensis sonorensis (10)
Arabidopsis thaliana (7)
Rattus norvegicus (3)
Saponaria officinalis (1)
Flaveria bidentis (1)
Pan troglodytes (1)
Solanum tuberosum (1)
Triticum aestivum (1)
Danio rerio (1)

Organisms

Homo sapiens (45)
Mus musculus (14)

Repository

ENA (62)
geo (39)
biostudies-arrayexpress (29)
pride (10)
EGA (2)
MassIVE (2)
MetaboLights (2)

Tissue

Cell culture (3)
Blood plasma (2)
Epithelial cell (2)
Ovarian cyst fluid (1)
Pleural mesothelioma cell (1)
Tear (1)
Peritoneal dialysis fluid (1)
Acute myeloid leukemia cell line (1)
Urine (1)

Disease

Malignant neoplasm of ovary (3)
Solid tumors (1)
Breast Neoplasms (1)
Lung Neoplasms (1)
Colorectal Neoplasms (1)
Central retinal vein occlusion (1)
Ovarian cancer (1)
Malignant mesothelioma (1)
Pancreatic ductal adenocarcinoma (1)

Technology Type

Mass Spectrometry (10)
Shotgun proteomics (5)
Mass spectrometry (2)
Data-independent acquisition (2)
Bottom-up proteomics (2)
Proteogenomics (1)
MSE (1)
SWATH MS (1)
SRM/MRM (1)
Affinity purification coupled with mass spectrometry proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (6)
NextSeq 500 (3)
Innopsys Innoscan (1)
Illumina NovaSeq X (1)
NextSeq 2000 (1)
Illumina HiSeq 1000 (1)
NextSeq 550 (1)
Orbitrap Fusion (1)
LTQ Orbitrap (1)
Q Exactive (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2025 (25)
2026 (13)
2022 (8)
2024 (6)
2006 (5)
2021 (5)
2014 (3)
2020 (3)
2019 (3)
2005 (2)
2023 (2)
2016 (1)
2013 (1)
2011 (1)
2009 (1)
2008 (1)
2017 (1)
2018 (1)

CHEBI ID

CHEBI:16628 (2)
CHEBI:17768 (2)
CHEBI:58148 (2)
CHEBI:70959 (2)
CHEBI:24149 (2)
CHEBI:89461 (2)
CHEBI:35704 (2)
CHEBI:17713 (2)
CHEBI:17172 (2)
CHEBI:16450 (2)
CHEBI:16675 (2)
CHEBI:28747 (2)
CHEBI:50129 (2)
CHEBI:60175 (2)
CHEBI:15611 (2)
CHEBI:17287 (2)
CHEBI:49033 (2)
CHEBI:15978 (2)
CHEBI:17677 (2)
CHEBI:184023 (2)
CHEBI:48928 (2)
CHEBI:17050 (2)
CHEBI:18295 (2)
CHEBI:18257 (2)
CHEBI:43580 (2)
CHEBI:15698 (2)
CHEBI:17140 (2)
CHEBI:17533 (2)
CHEBI:16708 (2)
CHEBI:17724 (2)

Metabolite Name

O-Tyrosine (2)
D-Alpha-aminobutyric acid (1)
Iodotyrosine (1)
All-trans-retinoic acid (1)
D-threo-Isocitric acid (1)
Methylglutaric acid (1)
Alpha-Hydroxyisobutyric acid (1)
Guanosine diphosphate (1)
3-Phosphoglyceric acid (1)
4-chlorobenzoic acid (1)
2-hydroxy-4-(methylthio)butanoic acid (1)
Isoleucylhydroxyproline* (1)
Leucylhydroxyproline* (1)
N-carboxymethylalanine (1)
3-hydroxydecanoylcarnitine (1)
S-(1,2-dicarboxyethyl)glutathione (1)
N-acetyl-isoputreanine (1)
N6,N6-dimethyllysine (1)
Ascorbic acid 3-sulfate* (1)
N,N-dimethylalanine (1)
3-amino-2-piperidone (1)
3-formylindole (1)
Hydroxyasparagine** (1)
Lyxonate (1)
N-stearoylserine* (1)
3-hydroxyoleoylcarnitine (1)
3-hydroxypalmitoylcarnitine (1)
2-butenoylglycine (1)
Palmitoleoyl ethanolamide* (1)
Sphingomyelin (d18:2/18:1)* (1)

First Public Date

2025 (20)
2026 (10)
2023 (7)
2021 (7)
2024 (6)
2022 (3)
2019 (3)
2014 (3)
2020 (2)
2016 (1)

Study status

Recruiting (2)
Not yet recruiting (1)
Not provided (1)

Study type

Transcription profiling by array (11)
RNA-seq of coding RNA (11)
Unknown experiment type (4)
Interventional (4)
RNA-seq of coding RNA from single cells (2)
Transcription profiling by SAGE (1)

Release Date

2025 (64)
2022 (47)
2023 (44)
2021 (44)
2024 (42)
2020 (40)
2016 (30)
2019 (26)
2018 (24)
2017 (23)
2026 (19)
2014 (18)
2015 (16)
2011 (11)
2013 (10)
2012 (8)
2006 (6)
2008 (5)
2010 (5)
2009 (4)
2005 (2)
2004 (2)
2007 (1)
2003 (1)
2002 (1)
1999 (1)
1998 (1)

Lab affiliation

Associate Director of Analytical Services, Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA (1)
Dr Ainhoa Mielgo, Tumour Microenvironment Lab, Department of Molecular and Clincial Cancer Medicine, University of Liverpool (1)
Systems Biology and Personalised Medicine, Walter & Eliza Hall Institute (1)
Professor, Department of Obstetrics and Gynecology at Institute of Clinical Sciences, Kvinnokliniken SU Östra 416 85 Gothenburg, Sweden (1)
Institute of Biomedical Chemistry, 119121 Moscow, 10 Pogodinskaya str., bld. 8, Russian Federation; tel.: +7 495 246 16 41; web: www.ibmc.msk.ru (1)
Technical Director Complex Carbohydrate Research Center 315 Riverbend Road Athens, Georgia 30602-4712 United States (1)
Biological Mass Spectrometry Lab Department of Translational Medicine (DiMeT) Center for Translational Research on Autoimmune & Allergic Diseases - CAAD University of Piemonte Orientale Corso Trieste 15/A, 28100, Novara, Italy (1)
The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China. (1)
Nemours Children’s Hospital, DE (1)
Ist. G. Gaslini (1)

Location

China (2)
United States (2)

Keyword

CAR T cells (1)
CAR T cell (1)
Fludarabine (1)
Cyclophosphamide (1)
CAR T Cell (1)
Autologous (1)
T Cell (1)
Mesothelin (1)
MSLN (1)
HLA-A2 (1)
Solid Tumors expressing MSLN (1)
Pancreatic (1)
Cell Therapy (1)
Gene Therapy (1)
Blocker (1)
PANC (1)
OVCA (1)

Previous page
1 / 62
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 62
Next page

Sort by:

Relevance

Page size

Structure of Cancer Antigen Mesothelin and Its Complex with Therapeutic Antibodies

Mesothelin is a differentiation antigen expressed at high levels on the surface of many cancers; its interaction with cancer antigen CA-125 can lead to metastasis. Mesothelin has been the subject of intensive investigations as a potential cancer antigen for immunotherapy. Structures of a fragment of...

ORGANISM(S): Homo sapiens (Human)

2023-05-10 | PXD034397 | Pride

Tear proteome revealed association of S100A family proteins and mesothelin with thrombosis in elderly patients with retinal vein occlusion

Tear samples collected from patients with central retinal vein occlusion (n=58) and group of healthy volunteers (n=30) were analyzed using a proteomic label-free absolute quantitative ap-proach. We found a large proportion (458 proteins with a frequency > 0.6) of tear proteome shared between healthy...

ORGANISM(S): Homo sapiens (Human)

2022-12-13 | PXD037021 | Pride

Retinal vein occlusion retinal hemostasis s100a protein mesothelin inflammation

Mesothelin targeted cancer immunotherapy.

Not available

S-EPMC2265108 | biostudies-literature

Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.

Not available

S-EPMC5595315 | biostudies-literature

Mesothelin-induced lysosomal biogenesis sustains neutrophil longevity to drive brain metastasis

PRJNA1525702 | ENA

Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line.